Pediatric status epilepticus
Should the diagnostic evaluation change?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The study by Singh et al.1 in this issue of Neurology® of new-onset seizures in children that present as status epilepticus (SE) expands our knowledge of this important area and provides valuable guidance for the diagnostic management of these children. New- onset seizures are common in children and SE is the presenting symptom in approximately 10%.2
The precise definition of SE is undergoing evolution and greatly depends on the question being asked and the conceptual basis. The standard definition is “a seizure or a series of seizures without full recovery in between lasting ≥30 minutes.”3,4 The conceptual framework underlying this definition is that status must persist long enough to produce cerebral injury different from any underlying insult that led to the seizure. For this injury-based definition, 30 minutes remains appropriate, as studies that demonstrate seizure-induced injury, notably in prolonged febrile seizures, all find that it takes at least 30 minutes, and usually considerably longer, to produce detectable injury in children.5 The optimal duration for defining SE is somewhat less clear when the definition relates to the failure of inhibitory mechanisms that ordinarily terminate a seizure before it becomes prolonged.2 Our studies reveal …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Prospective study of new-onset seizures presenting as status epilepticus in childhoodR. K. Singh, S. Stephens, M. M. Berl et al.Neurology, January 20, 2010 -
Special Article
Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Obstetrical complications and change in seizure frequencyReport of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy SocietyC. L. Harden, J. Hopp, T. Y. Ting et al.Neurology, April 27, 2009 -
Articles
Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complexJ. Y. Wu, N. Salamon, H. E. Kirsch et al.Neurology, February 01, 2010 -
Article
Time from convulsive status epilepticus onset to anticonvulsant administration in childrenIván Sánchez Fernández, Nicholas S. Abend, Satish Agadi et al.Neurology, May 06, 2015